Zdrowie i gospodarka · 3/15/2017
Considerations in Demonstrating Interchangeability With a Reference Product; Draft Guidance for Industry; Availability; Extension of Comment Period
The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice that appeared in the Federal Register of January 18, 2017. In the notice, FDA requested comments on "Considerations in Demonstrating Interchangeability with a Reference Product." The Agency is taking this action in response to several requests for an extension to allow interested persons additional time to submit comments.